Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
British Columbia Children's Hospital Research Institute, Vancouver, BC V5Z 4H4, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.
Am J Hum Genet. 2020 May 7;106(5):596-610. doi: 10.1016/j.ajhg.2020.03.008. Epub 2020 Apr 2.
Weaver syndrome (WS), an overgrowth/intellectual disability syndrome (OGID), is caused by pathogenic variants in the histone methyltransferase EZH2, which encodes a core component of the Polycomb repressive complex-2 (PRC2). Using genome-wide DNA methylation (DNAm) data for 187 individuals with OGID and 969 control subjects, we show that pathogenic variants in EZH2 generate a highly specific and sensitive DNAm signature reflecting the phenotype of WS. This signature can be used to distinguish loss-of-function from gain-of-function missense variants and to detect somatic mosaicism. We also show that the signature can accurately classify sequence variants in EED and SUZ12, which encode two other core components of PRC2, and predict the presence of pathogenic variants in undiagnosed individuals with OGID. The discovery of a functionally relevant signature with utility for diagnostic classification of sequence variants in EZH2, EED, and SUZ12 supports the emerging paradigm shift for implementation of DNAm signatures into diagnostics and translational research.
Weaver 综合征(WS)是一种过度生长/智力障碍综合征(OGID),由组蛋白甲基转移酶 EZH2 的致病变异引起,该基因编码多梳抑制复合物 2(PRC2)的核心组成部分。我们使用 187 名 OGID 患者和 969 名对照个体的全基因组 DNA 甲基化(DNAm)数据表明,EZH2 的致病变异会产生高度特异性和敏感的 DNAm 特征,反映出 WS 的表型。该特征可用于区分功能丧失型和功能获得型错义变异,并可检测体细胞嵌合现象。我们还表明,该特征可以准确地对编码 PRC2 另外两个核心成分 EED 和 SUZ12 的序列变异进行分类,并可预测 OGID 未确诊个体中存在致病变异。该发现具有功能相关性的特征,可用于 EZH2、EED 和 SUZ12 中序列变异的诊断分类,支持将 DNAm 特征应用于诊断和转化研究的新兴范式转变。